Medicare Enrolled
Dr. Isaac Kelly, M.D.
Urology Physician · Upland, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kelly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kelly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kelly
Dr. Isaac Kelly is an urology physician in Upland, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kelly performed 1,747 Medicare services across 1,079 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kelly received a total of $7,847 from 49 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kelly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 44% volume in CA
$7,847 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,747
Medicare services
Top 44% in CA for urology physician
1,079
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $98 | $330 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
372 | $68 | $220 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
304 | $3 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $121 | $500 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 83 | $136 | $600 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
66 | $106 | $415 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
65 | $8 | $70 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
63 | $196 | $725 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $97 | $322 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $29 | $125 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
26 | $49 | $270 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $64 | $220 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $2 | $15 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $116 | $330 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $163 | $795 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $49 | $205 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,847
Total received (2018-2024)
Avg $1,121/year across 7 years
Top 25% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,519 (83.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$849 (10.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$478 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$857
2023
$2,374
2022
$936
2021
$806
2020
$520
2019
$1,054
2018
$1,300
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$149
Axonics, Inc.
$87
UROGEN PHARMA, INC.
$70
Sumitomo Pharma America, Inc.
$68
Telix Pharmaceuticals
$66
Teleflex LLC
$62
Astellas Pharma US Inc
$56
Merck Sharp & Dohme LLC
$51
Janssen Biotech, Inc.
$46
Medtronic, Inc.
$42
PFIZER INC.
$28
Bayer Healthcare Pharmaceuticals Inc.
$26
Dendreon Pharmaceuticals LLC
$21
180 Medical, Inc.
$19
ABC Home Medical Supply, Inc.
$19
Endo Pharmaceuticals Inc.
$17
Valencia Technologies Corporation
$15
Antares Pharma, Inc.
$14
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$1,201
Coloplast Corp
$969
Bayer Healthcare Pharmaceuticals Inc.
$875
Astellas Pharma US Inc
$556
Teleflex LLC
$428
PFIZER INC.
$355
Janssen Biotech, Inc.
$341
Sumitomo Pharma America, Inc.
$340
Boston Scientific Corporation
$295
Axonics, Inc.
$288
ABBVIE INC.
$219
Myriad Genetic Laboratories, Inc.
$176
Endo Pharmaceuticals Inc.
$159
AbbVie Inc.
$143
Laborie Medical Technologies Corp.
$138
UROGEN PHARMA, INC.
$121
ABC Home Medical Supply, Inc.
$110
Merck Sharp & Dohme LLC
$87
Telix Pharmaceuticals
$83
Rochester Medical Corporation
$81
Medtronic, Inc.
$59
Bayer HealthCare Pharmaceuticals Inc.
$59
Tolmar, Inc.
$59
Myovant Sciences Inc.
$47
Hollister Incorporated
$46
COLOPLAST CORP
$43
Acerus Pharmaceuticals Corporation
$42
Medtronic USA, Inc.
$39
C. R. Bard, Inc. & Subsidiaries
$37
Antares Pharma, Inc.
$35
UroGen Pharma, Inc.
$31
NeoTract Inc.
$31
Amgen Inc.
$30
Cook Medical LLC
$30
AngioDynamics, Inc.
$29
KARL STORZ Endoscopy-America
$28
AbbVie, Inc.
$23
UROVANT SCIENCES INC
$23
Dendreon Pharmaceuticals LLC
$21
Blue Earth Diagnostics Limited
$21
Olympus America Inc.
$20
Travere Therapeutics, Inc.
$20
180 Medical, Inc.
$19
PROCEPT BioRobotics Corporation
$17
Supernus Pharmaceuticals, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
Valencia Technologies Corporation
$15
TISSUETECH, INC.
$14
Ambu Inc.
$10
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS · AQUABEAM ROBOTIC SYSTEM · Axonics · Axonics r-SNM System · Axumin · BOTOX · Cook Medical Dilation/Access · Cook Medical Stents · ELIGARD · ERLEADA · FEMALE INCONTINENCE · Flex-X · GEMTESA · GENERAL ERECTILE DYSFUNCTION · ILLUCCIX · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron Depot · MYRISK · Myrbetriq · NANOKNIFE · NEOX · Natesto · Nubeqa · ORGOVYX · Onli · PROLARIS · PROVENGE · Porges Coloplast · REZUM · Rezum Generator · SOLYX BLUE · SPACEOAR · SPACEOAR VUE · Seglentis · SpeediCath · TITAN · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · eCoin Device Kit · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
146
Per 100K population
6.7
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kelly is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kelly experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kelly performed 519 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kelly receive payments from pharmaceutical companies?
Yes. Dr. Kelly received a total of $7,847 from 49 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kelly's costs compare to other urology physicians in Upland?
Dr. Kelly's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kelly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Upland
Browse urology physicians in Upland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology